Furthermore, it has been shown that patients with GBM with high levels of glycolysis-related genes, including HK2 and PKM2, and low levels of mitochondrial metabolism-related genes, such as SDHB and COX5A, related to TCA cycle and oxidative phosphorylation (OXPHOS), have poor survival rates. Here, COX5A is linked to glioblastoma.